KRAS G12V
Clinical trials for KRAS G12V explained in plain language.
Never miss a new study
Get alerted when new KRAS G12V trials appear
Sign up with your email to follow new studies for KRAS G12V, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test 'Living Vaccine' to train immune system against tough cancers
Disease control OngoingThis early-stage trial is testing a personalized cancer vaccine made from a patient's own immune cells. The cells are engineered to target two specific markers found on some advanced solid tumors and are given alongside standard immunotherapy drugs. The main goals are to see if t…
Matched conditions: KRAS G12V
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New shot aims to stop aggressive cancers from coming back
Disease control OngoingThis trial is testing a new immunotherapy called ELI-002 7P. It is for people with pancreatic or colorectal cancer that has a specific genetic change (KRAS or NRAS mutation) and who have already had surgery and chemotherapy. The goal is to see if this treatment can safely help th…
Matched conditions: KRAS G12V
Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC